Victory Capital Holdings VCTR 深 滬
交易中 12-26 09:51:44 美东时间
64.18
-0.050
-0.08%
華盛通- 最 高64.30
- 今 開64.12
- 成交量 5974股
- 最 低 64.09
- 昨 收 64.23
- 總市值 42.86亿
- 52周最高 72.02
- 市盈率 靜 14.65
- 換手率 0.01%
- 52周最低 45.53
- 委 比 22.22%
- 總股本 6678.34万
- 歷史最高 72.02
- 量 比 1.70
- 振 幅 0.33%
- 歷史最低 0.635
- 每 手 1
- 風險率 4.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
12-18 10:54
Victory Capital Holdings Adds Three New Undertakings For Collective Investment In Transferable Securities Through Strategic Partnership With Amundi
Victory Capital Holdings, Inc. (NASDAQ:VCTR) ("Victory Capital" or the "Company"), today announced that it has added three new Undertakings for Collective Investment in Transferable Securities (UCITS) through its
12-12 05:35
Victory Capital reports November 2025 total client assets
Victory Capital Holdings (VCTR) said total client assets were $317.7 billion as of November 30, up from $315.8 billion at the end of October. Total assets under management rose to $314.8 billion from ...
12-11 05:39
Victory Capital Reports Stable AUM Growth in October
Victory Capital Holdings ( ($VCTR) ) has provided an update. On November 11, 20...
11-13 05:58
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
JP Morgan Maintains Neutral on Victory Capital Holdings, Lowers Price Target to $70
JP Morgan analyst Michael Cho maintains Victory Capital Holdings (NASDAQ:VCTR) with a Neutral and lowers the price target from $71 to $70.
11-11 01:48
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Exploring Hercules Capital's Earnings Expectations
Hercules Capital (NYSE:HTGC) is gearing up to announce its quarterly earnings o...
10-30 03:01
美股大行评级 | 富国银行上调苹果目标价升至290美元；"卖出"！花旗下调NuScale Power、阿特斯太阳能评级
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从30美元升至44美元；Piper Sandler：维持Vital Energy"中性"评级，目标价从16美元升至30美元
10-22 10:10
What to Expect from Cohen & Steers's Earnings
Cohen & Steers (NYSE:CNS) will release its quarterly earnings report on Thu...
10-15 23:02
